1. Technology overview
ScandiDos AB is a company headquartered in Uppsala Science Park, Sweden, founded in 2002, with its first product launched in 2006. It supplies quality assurance systems that help radiotherapy departments confirm that cancer radiation treatments are delivered correctly, and it is listed on Nasdaq First North Stockholm.
Delta4 Phantom+ is a patient-specific QA system that uses two orthogonal detector planes and calculation software for independent 4D dose verification near the isocenter, with results immediately after delivery. It supports IMRT, VMAT, SRS/SBRT, Halcyon, MR-guided RT, Radixact and TomoTherapy. Delta4 SRS Pro, shown in 2026, uses three orthogonal planes with 2,916 diodes for stereotactic treatments. The page cites more than 1,100 systems installed in over 55 countries.
2. Highlighted features & specifications
- 4D dose verification: independent dose measurement in the isocenter region using two orthogonal detector planes.
- Instant analysis: results are available right after delivery.
- Broad technique support: IMRT, VMAT, SRS/SBRT, Halcyon, MR-guided RT, Radixact and TomoTherapy.
- Multi-level comparison: dose compared at fraction, beam or segment level.
- Add-on software: Delta4 Insight, DVH Anatomy, Machine QA 3D and Statistics Module are listed on the site.
- SRS Pro: three orthogonal planes with 2,916 diodes and support for 90-degree couch rotations.
3. Potential application
Radiotherapy departments in Vietnamese oncology hospitals could use Phantom+ for pre-treatment verification of IMRT and VMAT plans. Centres introducing stereotactic radiosurgery could add SRS-focused QA. Medical physics teams could use the statistics tools to monitor plan quality over time.
4. Benefits
Independent 4D dose verification gives results immediately after delivery. One system supports many techniques including IMRT, VMAT and SRS/SBRT. Comparison at fraction, beam or segment level helps explain disagreements. Installed base of more than 1,100 systems at over 850 customers supports reliability.
5. Market trends & opportunities
Radiotherapy centres are adopting stereotactic and adaptive techniques that require tighter patient-specific quality assurance. Vietnam and Southeast Asia are adding linear accelerators in major hospitals, which increases demand for QA equipment; ScandiDos lists a sales office in Malaysia.
6. Other information
ScandiDos AB (publ), Dag Hammarskjölds väg 52A, Uppsala, Sweden, listed on Nasdaq First North Stockholm (SDOS). Sales offices in the USA, Malaysia and France, direct sales in the Nordics and distributors in over 50 countries. MDR certification for the Delta4 Phantom+ line announced in November 2023. A rights issue of about 12.8 MSEK was completed in July 2026.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
RETAIL E-COMMERCE: AI AND REAL-TIME DATA ARE TRANSFORMING HOW RETAIL BUSINESSES OPERATE








































